Hemarina
Hemarina develops therapeutic oxygen carriers based on the extracellular hemoglobin of the marine worm Arenicola marina. The company produces medical devices such as HEMO2life for organ graft preservation and other products for wound healing, dentistry, and cell culture. Its technology targets the healthcare and biotechnology markets by providing a universal oxygen carrier compatible with all blood groups.
Biotechnology
Healthcare
Medical Devices
Healthtech
Funding summary
- Total raised
- €8.0M
- Funding rounds
- 1
Investors in Hemarina
Investors on record for Hemarina. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Hemarina?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors